Skip to main content
. 2021 Feb 19;42(7):e849–e857. doi: 10.1097/MAO.0000000000003120

FIG. 2.

FIG. 2

Modeled pharmacokinetics of FX-322 in the human inner ear. Calculated human cochlear distributions of CHIR99021 and valproic acid (VPA) as a function of cochlear distance and time based on elimination measurements obtained in guinea pig pharmacokinetic studies. Calculations include entry, perilymph kinetic and middle ear kinetic parameters, as summarized in Table S3.